Mortality reduction and cost-effectiveness of performing hysterectomy at the time of RRSO for prophylaxis against serous/serous-like uterine cancers in BRCA1 mutation carriers
Publication
, Conference
Havrilesky, LJ; Moss, HA; Myers, ER; Kauff, ND
Published in: Gynecologic Oncology
June 2017
Duke Scholars
Published In
Gynecologic Oncology
DOI
ISSN
0090-8258
Publication Date
June 2017
Volume
145
Start / End Page
45 / 45
Publisher
Elsevier BV
Related Subject Headings
- Oncology & Carcinogenesis
- 3215 Reproductive medicine
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
- 1114 Paediatrics and Reproductive Medicine
- 1112 Oncology and Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Havrilesky, L. J., Moss, H. A., Myers, E. R., & Kauff, N. D. (2017). Mortality reduction and cost-effectiveness of performing hysterectomy at the time of RRSO for prophylaxis against serous/serous-like uterine cancers in BRCA1 mutation carriers. In Gynecologic Oncology (Vol. 145, pp. 45–45). Elsevier BV. https://doi.org/10.1016/j.ygyno.2017.03.114
Havrilesky, L. J., H. A. Moss, E. R. Myers, and N. D. Kauff. “Mortality reduction and cost-effectiveness of performing hysterectomy at the time of RRSO for prophylaxis against serous/serous-like uterine cancers in BRCA1 mutation carriers.” In Gynecologic Oncology, 145:45–45. Elsevier BV, 2017. https://doi.org/10.1016/j.ygyno.2017.03.114.
Havrilesky LJ, Moss HA, Myers ER, Kauff ND. Mortality reduction and cost-effectiveness of performing hysterectomy at the time of RRSO for prophylaxis against serous/serous-like uterine cancers in BRCA1 mutation carriers. In: Gynecologic Oncology. Elsevier BV; 2017. p. 45–45.
Havrilesky, L. J., et al. “Mortality reduction and cost-effectiveness of performing hysterectomy at the time of RRSO for prophylaxis against serous/serous-like uterine cancers in BRCA1 mutation carriers.” Gynecologic Oncology, vol. 145, Elsevier BV, 2017, pp. 45–45. Crossref, doi:10.1016/j.ygyno.2017.03.114.
Havrilesky LJ, Moss HA, Myers ER, Kauff ND. Mortality reduction and cost-effectiveness of performing hysterectomy at the time of RRSO for prophylaxis against serous/serous-like uterine cancers in BRCA1 mutation carriers. Gynecologic Oncology. Elsevier BV; 2017. p. 45–45.
Published In
Gynecologic Oncology
DOI
ISSN
0090-8258
Publication Date
June 2017
Volume
145
Start / End Page
45 / 45
Publisher
Elsevier BV
Related Subject Headings
- Oncology & Carcinogenesis
- 3215 Reproductive medicine
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
- 1114 Paediatrics and Reproductive Medicine
- 1112 Oncology and Carcinogenesis